BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Murata M, Tagawa M, Kimura M, Kimura H, Watanabe S, Saisho H. Analysis of a germ line polymorphism of the p53 gene in lung cancer patients; discrete results with smoking history. Carcinogenesis. 1996;17:261-264. [PMID: 8625447 DOI: 10.1093/carcin/17.2.261] [Cited by in Crossref: 78] [Cited by in F6Publishing: 79] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Jafrin S, Aziz MA, Anonna SN, Akter T, Naznin NE, Reza S, Islam MS. Association of TP53 Codon 72 Arg>Pro Polymorphism with Breast and Lung Cancer Risk in the South Asian Population: A Meta-Analysis. Asian Pac J Cancer Prev 2020;21:1511-9. [PMID: 32592343 DOI: 10.31557/APJCP.2020.21.6.1511] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
2 Elshazli RM, Toraih EA, Elgaml A, Kandil E, Fawzy MS. Genetic polymorphisms of TP53 (rs1042522) and MDM2 (rs2279744) and colorectal cancer risk: An updated meta-analysis based on 59 case-control studies. Gene 2020;734:144391. [PMID: 32001373 DOI: 10.1016/j.gene.2020.144391] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
3 Zhang Y, Zhang D, Zhao L, Sun L, Dong Q, Cheng L, Cheng R. Association between p53 Arg72Pro polymorphism and colorectal cancer risk in Asian population: a meta-analysis. Current Problems in Cancer 2018;42:582-92. [DOI: 10.1016/j.currproblcancer.2018.08.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
4 Dong Z, Zheng L, Liu W, Wang C. Association of mRNA expression of TP53 and the TP53 codon 72 Arg/Pro gene polymorphism with colorectal cancer risk in Asian population: a bioinformatics analysis and meta-analysis. Cancer Manag Res 2018;10:1341-9. [PMID: 29872345 DOI: 10.2147/CMAR.S164892] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
5 Tian X, Dai S, Sun J, Jiang S, Jiang Y. The association between the TP53 Arg72Pro polymorphism and colorectal cancer: An updated meta-analysis based on 32 studies. Oncotarget 2017;8:1156-65. [PMID: 27901479 DOI: 10.18632/oncotarget.13589] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
6 Verheijen F, Sprong M, Kloosterman J, Blaauw G, Thijssen J, Blankenstein M. TP53 Mutations in Human Meningiomas. Int J Biol Markers 2002;17:42-8. [DOI: 10.1177/172460080201700105] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
7 Kumari A, Bahl C, Singh N, Behera D, Sharma S. Association of p53 codon 72 polymorphism and survival of North Indian lung cancer patients treated with platinum-based chemotherapy. Mol Biol Rep 2016;43:1383-94. [DOI: 10.1007/s11033-016-4072-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
8 Omori S, Yoshida S, Kennedy SH, Negoro K, Hamana S, Barlow DH, Maruo T. Polymorphism at Codon 72 of the p53 Gene Is Not associated With Endometriosis in a Japanese Population. Journal of the Society for Gynecologic Investigation 2016;11:232-6. [DOI: 10.1016/j.jsgi.2003.11.004] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.5] [Reference Citation Analysis]
9 Abderrahmane R, Louhibi L, Moghtit FZ, Boubekeur A, Benseddik K, Boudjema A, Benrrahal F, Aberkane M, Fodil M, Saidi-mehtar N. TP53 Arg 72Pro and MDM2 SNP309 Polymorphisms and Colorectal Cancer Risk: A West Algerian Population Study. Pathol Oncol Res 2015;21:629-35. [DOI: 10.1007/s12253-014-9867-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
10 Heinze B, Herrmann LJM, Fassnacht M, Ronchi CL, Willenberg HS, Quinkler M, Reisch N, Zink M, Allolio B, Hahner S. Less common genotype variants of TP53 polymorphisms are associated with poor outcome in adult patients with adrenocortical carcinoma. European Journal of Endocrinology 2014;170:707-17. [DOI: 10.1530/eje-13-0788] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
11 Zhao L, Zhao X, Wu X, Tang W. Association of p53 Arg72Pro polymorphism with esophageal cancer: a meta-analysis based on 14 case-control studies. Genet Test Mol Biomarkers 2013;17:721-6. [PMID: 23844939 DOI: 10.1089/gtmb.2013.0103] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
12 Wang S, Lan X, Tan S, Wang S, Li Y. P53 codon 72 Arg/Pro polymorphism and lung cancer risk in Asians: an updated meta-analysis. Tumour Biol 2013;34:2511-20. [PMID: 23812725 DOI: 10.1007/s13277-013-0678-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
13 Zhou C, Chen H, Wang A. P53 codon 72 polymorphism and lung cancer risk: evidence from 27,958 subjects. Tumor Biol 2013;34:2961-9. [DOI: 10.1007/s13277-013-0859-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
14 Qiao Q, Hu W. The association between TP53 Arg72Pro polymorphism and lung cancer susceptibility: evidence from 30,038 subjects. Lung 2013;191:369-77. [PMID: 23595658 DOI: 10.1007/s00408-013-9461-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
15 Tilak AR, Kumar S, Pant MC, Mathur N, Kumar A. Polymorphism Arg72Pro of p53 confers susceptibility to squamous cell carcinoma of lungs in a North Indian population. DNA Cell Biol 2013;32:66-72. [PMID: 23317414 DOI: 10.1089/dna.2012.1792] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
16 Manne U, Shanmugam C, Katkoori VR, Bumpers HL, Grizzle WE. Development and progression of colorectal neoplasia. Cancer Biomark. 2010;9:235-265. [PMID: 22112479 DOI: 10.3233/cbm-2011-0160] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
17 Engin AB, Karahalil B, Karakaya AE, Engin A. Association between XRCC1 ARG399GLN and P53 ARG72PRO polymorphisms and the risk of gastric and colorectal cancer in Turkish population. Arh Hig Rada Toksikol. 2011;62:207-214. [PMID: 21971103 DOI: 10.2478/10004-1254-62-2011-2098] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
18 Liu L, Wang K, Zhu ZM, Shao JH. Associations between P53 Arg72Pro and development of digestive tract cancers: a meta-analysis. Arch Med Res 2011;42:60-9. [PMID: 21376265 DOI: 10.1016/j.arcmed.2011.01.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
19 Ihsan R, Devi TR, Yadav DS, Mishra AK, Sharma J, Zomawia E, Verma Y, Phukan R, Mahanta J, Kataki AC, Kapur S, Saxena S. Investigation on the Role of p53 Codon 72 Polymorphism and Interactions with Tobacco, Betel Quid, and Alcohol in Susceptibility to Cancers in a High-Risk Population from North East India. DNA and Cell Biology 2011;30:163-71. [DOI: 10.1089/dna.2010.1119] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
20 Wang JJ, Zheng Y, Sun L, Wang L, Yu PB, Dong JH, Zhang L, Xu J, Shi W, Ren YC. TP53 codon 72 polymorphism and colorectal cancer susceptibility: a meta-analysis. Mol Biol Rep 2011;38:4847-53. [PMID: 21140221 DOI: 10.1007/s11033-010-0619-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
21 Francisco G, Menezes PR, Eluf-Neto J, Chammas R. Arg72Pro TP53 polymorphism and cancer susceptibility: a comprehensive meta-analysis of 302 case-control studies. Int J Cancer. 2011;129:920-930. [PMID: 20886596 DOI: 10.1002/ijc.25710] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 3.9] [Reference Citation Analysis]
22 Joshi AM, Budhathoki S, Ohnaka K, Mibu R, Tanaka M, Kakeji Y, Maehara Y, Okamura T, Ikejiri K, Futami K. TP53 R72P and MDM2 SNP309 polymorphisms and colorectal cancer risk: the Fukuoka Colorectal Cancer Study. Jpn J Clin Oncol. 2011;41:232-238. [PMID: 21051533 DOI: 10.1093/jjco/hyq200] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
23 Tang NP, Wu YM, Wang B, Ma J. Systematic review and meta-analysis of the association between P53 codon 72 polymorphism and colorectal cancer. Eur J Surg Oncol. 2010;36:431-438. [PMID: 20363586 DOI: 10.1016/j.ejso.2010.03.010] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
24 Chua HW, Ng D, Choo S, Lum SS, Li H, Soh LY, Sabapathy K, Seow A. Effect of MDM2 SNP309 and p53 codon 72 polymorphisms on lung cancer risk and survival among non-smoking Chinese women in Singapore. BMC Cancer 2010;10:88. [PMID: 20219101 DOI: 10.1186/1471-2407-10-88] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 3.0] [Reference Citation Analysis]
25 Yan L, Zhang D, Chen C, Mao Y, Xie Y, Li Y, Huang Y, Han B. TP53 Arg72Pro polymorphism and lung cancer risk: a meta-analysis. Int J Cancer 2009;125:2903-11. [PMID: 19623649 DOI: 10.1002/ijc.24603] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
26 Sobti RC, Kaur P, Kaur S, Janmeja AK, Jindal SK, Kishan J, Raimondi S. Impact of interaction of polymorphic forms of p53 codon 72 and N-acetylation gene (NAT2) on the risk of lung cancer in the North Indian population. DNA Cell Biol 2009;28:443-9. [PMID: 19558213 DOI: 10.1089/dna.2008.0797] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
27 Dai S, Mao C, Jiang L, Wang G, Cheng H. P53 polymorphism and lung cancer susceptibility: a pooled analysis of 32 case-control studies. Hum Genet 2009;125:633-8. [PMID: 19357867 DOI: 10.1007/s00439-009-0664-3] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
28 Zhang Z. The risk of gastric cancer in patients with duodenal and gastric ulcer: research progresses and clinical implications. J Gastrointest Cancer 2007;38:38-45. [PMID: 19065723 DOI: 10.1007/s12029-008-9015-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
29 Li Y, Qiu LX, Shen XK, Lv XJ, Qian XP, Song Y. A meta-analysis of TP53 codon 72 polymorphism and lung cancer risk: evidence from 15,857 subjects. Lung Cancer 2009;66:15-21. [PMID: 19178978 DOI: 10.1016/j.lungcan.2008.12.009] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
30 Spivack SD, Fasco MJ, Walker VE, Kaminsky LS. The Molecular Epidemiology of Lung Cancer. Critical Reviews in Toxicology 2008;27:319-65. [DOI: 10.3109/10408449709089898] [Cited by in Crossref: 64] [Cited by in F6Publishing: 50] [Article Influence: 4.6] [Reference Citation Analysis]
31 Honma HN, De Capitani EM, Perroud MW, Barbeiro AS, Toro IF, Costa DB, Lima CS, Zambon L. Influence of p53 codon 72 exon 4, GSTM1, GSTT1 and GSTP1*B polymorphisms in lung cancer risk in a Brazilian population. Lung Cancer 2008;61:152-62. [DOI: 10.1016/j.lungcan.2007.12.014] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.0] [Reference Citation Analysis]
32 Zhu ZZ, Wang AZ, Jia HR, Jin XX, He XL, Hou LF, Zhu G. Association of the TP53 codon 72 polymorphism with colorectal cancer in a Chinese population. Jpn J Clin Oncol. 2007;37:385-390. [PMID: 17599946 DOI: 10.1093/jjco/hym034] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 2.7] [Reference Citation Analysis]
33 Shao Y, Tan W, Zhang S. P53 gene codon 72 polymorphism and risk of esophageal squamous cell carcinoma: a case/control study in a Chinese population. Dis Esophagus 2008;21:139-43. [PMID: 18269649 DOI: 10.1111/j.1442-2050.2007.00746.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
34 Tsuchiya Y, Kiyohara C, Sato T, Nakamura K, Kimura A, Yamamoto M. Polymorphisms of cytochrome P450 1A1, glutathione S-transferase class mu, and tumour protein p53 genes and the risk of developing gallbladder cancer in Japanese. Clin Biochem. 2007;40:881-886. [PMID: 17531965 DOI: 10.1016/j.clinbiochem.2007.04.005] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
35 Kuroda Y, Nakao H, Ikemura K, Katoh T. Association between the TP53 codon72 polymorphism and oral cancer risk and prognosis. Oral Oncol 2007;43:1043-8. [PMID: 17306604 DOI: 10.1016/j.oraloncology.2006.12.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
36 Nadji SA, Mahmoodi M, Ziaee AA, Naghshvar F, Torabizadeh J, Yahyapour Y, Nategh R, Mokhtari-Azad T. An increased lung cancer risk associated with codon 72 polymorphism in the TP53 gene and human papillomavirus infection in Mazandaran province, Iran. Lung Cancer 2007;56:145-51. [PMID: 17208332 DOI: 10.1016/j.lungcan.2006.12.006] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
37 Alkhalaf M, Al-bustan S, Hamoda H, Abdella N. Polymorphism of p53 gene codon 72 in Kuwaiti with coronary artery disease and diabetes. International Journal of Cardiology 2007;115:1-6. [DOI: 10.1016/j.ijcard.2006.01.029] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
38 Koushik A, Tranah GJ, Ma J, Stampfer MJ, Sesso HD, Fuchs CS, Giovannucci EL, Hunter DJ. p53 Arg72Pro polymorphism and risk of colorectal adenoma and cancer. Int J Cancer. 2006;119:1863-1868. [PMID: 16721787 DOI: 10.1002/ijc.22057] [Cited by in Crossref: 53] [Cited by in F6Publishing: 51] [Article Influence: 3.3] [Reference Citation Analysis]
39 Chung WC, Lee KM, Lee BI, Chun JS, Lee SY, Chang UI, Park SH, Yang JM, Choi KY, Chung IS. P53 genetic polymorphism of gastric cancer in Korea. Korean J Intern Med 2006;21:28-32. [PMID: 16646561 DOI: 10.3904/kjim.2006.21.1.28] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
40 Pérez LO, Abba MC, Dulout FN, Golijow CD. Evaluation of p53 codon 72 polymorphism in adenocarcinomas of the colon and rectum in La Plata, Argentina. World J Gastroenterol 2006; 12(9): 1426-1429 [PMID: 16552814 DOI: 10.3748/wjg.v12.i9.1426] [Cited by in CrossRef: 45] [Cited by in F6Publishing: 43] [Article Influence: 2.8] [Reference Citation Analysis]
41 Pezeshki A, Sari-aslanl F, Ghaderi A, Doroudchi M. p53 codon 72 polymorphism in basal cell carcinoma of the skin. Pathol Oncol Res 2006;12:29-33. [DOI: 10.1007/bf02893428] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
42 Szymanowska A, Jassem E, Dziadziuszko R, Borg A, Limon J, Kobierska-Gulida G, Rzyman W, Jassem J. Increased risk of non-small cell lung cancer and frequency of somatic TP53 gene mutations in Pro72 carriers of TP53 Arg72Pro polymorphism. Lung Cancer 2006;52:9-14. [PMID: 16499995 DOI: 10.1016/j.lungcan.2005.12.007] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 2.3] [Reference Citation Analysis]
43 Twu C, Jiang R, Shu C, Lin J. Association of p53 Codon 72 Polymorphism with Risk of Hypopharyngeal Squamous Cell Carcinoma in Taiwan. Journal of the Formosan Medical Association 2006;105:99-104. [DOI: 10.1016/s0929-6646(09)60330-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
44 Lee JM, Shun CT, Wu MT, Chen YY, Yang SY, Hung HI, Chen JS, Hsu HH, Huang PM, Kuo SW, Lee YC. The associations of p53 overexpression with p53 codon 72 genetic polymorphism in esophageal cancer. Mutat Res 2006;594:181-8. [PMID: 16318864 DOI: 10.1016/j.mrfmmm.2005.09.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
45 Pérez-Pérez GI, Bosques-Padilla FJ, Crosatti ML, Tijerina-Menchaca R, Garza-González E. Role of p53 codon 72 polymorphism in the risk of development of distal gastric cancer. Scand J Gastroenterol 2005;40:56-60. [PMID: 15841715 DOI: 10.1080/00365520410009456] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 1.9] [Reference Citation Analysis]
46 DeMarini DM. Genotoxicity of tobacco smoke and tobacco smoke condensate: a review. Mutat Res 2004;567:447-74. [PMID: 15572290 DOI: 10.1016/j.mrrev.2004.02.001] [Cited by in Crossref: 336] [Cited by in F6Publishing: 321] [Article Influence: 19.8] [Reference Citation Analysis]
47 Zhang ZW, Newcomb P, Hollowood A, Moganaden, Gupta J, Feakins R, Storey A, Farthing MJ, Alderson D, Holly J. A comparison study of gastric cancer risk in patients with duodenal and gastric ulcer: roles of gastric mucosal histology and p53 codon 72 polymorphism. Dig Dis Sci 2004;49:254-9. [PMID: 15104366 DOI: 10.1023/b:ddas.0000017447.02220.f5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
48 Zhang ZW, Newcomb P, Hollowood A, Moganaden J, Feakins R, Storey A, Farthing MJ, Alderson D, Holly J. A comparison study of gastric cancer risk in patients with duodenal and gastric ulcer: roles of gastric mucosal histology and p53 codon 72 polymorphism. Dig Dis Sci. 2004;49:254-259. [PMID: 15104366 DOI: 10.1023/B: DDAS.0000017447.02220.f5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
49 Su L, Sai Y, Fan R, Thurston SW, Miller DP, Zhou W, Wain JC, Lynch TJ, Liu G, Christiani DC. P53 (codon 72) and P21 (codon 31) polymorphisms alter in vivo mRNA expression of p21. Lung Cancer 2003;40:259-66. [PMID: 12781424 DOI: 10.1016/s0169-5002(03)00081-3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.0] [Reference Citation Analysis]
50 Kiyohara C, Otsu A, Shirakawa T, Fukuda S, Hopkin JM. Genetic polymorphisms and lung cancer susceptibility: a review. Lung Cancer 2002;37:241-56. [PMID: 12234692 DOI: 10.1016/s0169-5002(02)00107-1] [Cited by in Crossref: 99] [Cited by in F6Publishing: 86] [Article Influence: 5.2] [Reference Citation Analysis]
51 Kuroda Y, Tsukino H, Nakao H, Imai H, Katoh T. p53 Codon 72 polymorphism and urothelial cancer risk. Cancer Lett. 2003;189:77-83. [PMID: 12445680 DOI: 10.1016/s0304-3835(02)00518-9] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 2.1] [Reference Citation Analysis]
52 Manfredi S, Masetti S, Botto N, Colombo MG, Terrazzi M, Vassalle C, Biagini A, Andreassi MG. p53 codon 72 polymorphism in coronary artery disease: No evidence for association with increased risk or micronucleus frequency. Environ Mol Mutagen 2002;40:110-5. [DOI: 10.1002/em.10098] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
53 Saranath D, Khan Z, Tandle AT, Dedhia P, Sharma B, Contractor R, Shrivastava S, Dinshaw K. HPV16/18 prevalence in cervical lesions/cancers and p53 genotypes in cervical cancer patients from India. Gynecol Oncol. 2002;86:157-162. [PMID: 12144822 DOI: 10.1006/gyno.2002.6735] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 2.0] [Reference Citation Analysis]
54 Hiyama T, Tanaka S, Kitadai Y, Ito M, Sumii M, Yoshihara M, Shimamoto F, Haruma K, Chayama K. p53 Codon 72 polymorphism in gastric cancer susceptibility in patients withHelicobacter pylori-associated chronic gastritis. Int J Cancer 2002;100:304-8. [DOI: 10.1002/ijc.10483] [Cited by in Crossref: 54] [Cited by in F6Publishing: 50] [Article Influence: 2.7] [Reference Citation Analysis]
55 Tsai MH, Lin CD, Hsieh YY, Chang FC, Tsai FJ, Chen WC, Tsai CH. Prognostic significance of the proline form of p53 codon 72 polymorphism in nasopharyngeal carcinoma. Laryngoscope. 2002;112:116-119. [PMID: 11802048 DOI: 10.1097/00005537-200201000-00020] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 2.0] [Reference Citation Analysis]
56 Nagpal JK, Patnaik S, Das BR. Prevalence of high-risk human papilloma virus types and its association with P53 codon 72 polymorphism in tobacco addicted oral squamous cell carcinoma (oscc) patients of Eastern India. Int J Cancer 2002;97:649-53. [DOI: 10.1002/ijc.10112] [Cited by in Crossref: 78] [Cited by in F6Publishing: 78] [Article Influence: 3.9] [Reference Citation Analysis]
57 Sourvinos G, Rizos E, Spandidos D. p53 codon 72 polymorphism is linked to the development and not the progression of benign and malignant laryngeal tumours. Oral Oncology 2001;37:572-8. [DOI: 10.1016/s1368-8375(00)00139-1] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.0] [Reference Citation Analysis]
58 Tandle AT, Sanghvi V, Saranath D. Determination of p53 genotypes in oral cancer patients from India. Br J Cancer 2001;84:739-42. [PMID: 11259085 DOI: 10.1054/bjoc.2000.1674] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 1.4] [Reference Citation Analysis]
59 Peixoto Guimaraes D, Hsin Lu S, Snijders P, Wilmotte R, Herrero R, Lenoir G, Montesano R, Meijer CJ, Walboomers J, Hainaut P. Absence of association between HPV DNA, TP53 codon 72 polymorphism, and risk of oesophageal cancer in a high-risk area of China. Cancer Lett. 2001;162:231-235. [PMID: 11146230 DOI: 10.1016/s0304-3835(00)00643-1] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 1.8] [Reference Citation Analysis]
60 Kim JW, Roh JW, Park NH, Song YS, Kang SB, Lee HP. Polymorphism of TP53 codon 72 and the risk of cervical cancer among Korean women. Am J Obstet Gynecol 2001;184:55-8. [PMID: 11174479 DOI: 10.1067/mob.2001.108329] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 1.2] [Reference Citation Analysis]
61 Lee JM, Lee YC, Yang SY, Shi WL, Lee CJ, Luh SP, Chen CJ, Hsieh CY, Wu MT. Genetic polymorphisms of p53 and GSTP1, but not NAT2,are associated with susceptibility to squamous-cell carcinoma of the esophagus. Int J Cancer. 2000;89:458-464. [PMID: 11008209 DOI: 10.1002/1097-0215(20000920)89:5%3C458::AID-IJC10%3E3.0.CO;2-R] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
62 Nishikawa A, Fujimoto T, Akutagawa N, Iwasaki M, Takeuchi M, Fujinaga K, Kudo R. p53 Polymorphism (codon-72) has no correlation with the development and the clinical features of cervical cancer. Int J Gynecol Cancer 2000;10:402-7. [PMID: 11240705 DOI: 10.1046/j.1525-1438.2000.010005402.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 1.1] [Reference Citation Analysis]
63 Summersgill KF, Smith EM, Kirchner H, Haugen TH, Turek LP. p53 polymorphism, human papillomavirus infection in the oral cavity, and oral cancer. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology 2000;90:334-9. [DOI: 10.1067/moe.2000.107359] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 2.0] [Reference Citation Analysis]
64 Malcolm EK, Baber GB, Boyd JC, Stoler MH. Polymorphism at codon 72 of p53 is not associated with cervical cancer risk. Mod Pathol 2000;13:373-8. [PMID: 10786802 DOI: 10.1038/modpathol.3880061] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.0] [Reference Citation Analysis]
65 Shepherd T, Tolbert D, Benedetti J, Macdonald J, Stemmermann G, Wiest J, DeVoe G, Miller MA, Wang J, Noffsinger A. Alterations in exon 4 of the p53 gene in gastric carcinoma. Gastroenterology. 2000;118:1039-1044. [PMID: 10833478 DOI: 10.1016/s0016-5085(00)70356-8] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 1.6] [Reference Citation Analysis]
66 Marin MC, Jost CA, Brooks LA, Irwin MS, O’Nions J, Tidy JA, James N, McGregor JM, Harwood CA, Yulug IG. A common polymorphism acts as an intragenic modifier of mutant p53 behaviour. Nat Genet. 2000;25:47-54. [PMID: 10802655 DOI: 10.1038/75586] [Cited by in Crossref: 326] [Cited by in F6Publishing: 334] [Article Influence: 14.8] [Reference Citation Analysis]
67 Nakano Y, Naoe T, Kiyoi H, Kunishima S, Minami S, Miyawaki S, Asou N, Kuriyama K, Saito H, Ohno R. Poor clinical significance of p53 gene polymorphism in acute myeloid leukemia. Leukemia Research 2000;24:349-52. [DOI: 10.1016/s0145-2126(99)00187-3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 0.9] [Reference Citation Analysis]
68 Mcwilliams JE, Evans AJ, Beer TM, Andersen PE, Cohen JI, Everts EC, Henner WD. Genetic polymorphisms in head and neck cancer risk. Head Neck 2000;22:609-17. [DOI: 10.1002/1097-0347(200009)22:6<609::aid-hed10>3.0.co;2-l] [Cited by in Crossref: 48] [Cited by in F6Publishing: 43] [Article Influence: 2.2] [Reference Citation Analysis]
69 Malkin D, Brown EJ, Zipursky A. The Role of p53 in Megakaryocyte Differentiation and the Megakaryocytic Leukemias of Down Syndrome. Cancer Genetics and Cytogenetics 2000;116:1-5. [DOI: 10.1016/s0165-4608(99)00072-2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 1.1] [Reference Citation Analysis]
70 Lee J, Lee Y, Yang S, Shi W, Lee C, Luh S, Chen C, Hsieh C, Wu M. Genetic polymorphisms ofp53 andGSTP1,but notNAT2,are associated with susceptibility to squamous-cell carcinoma of the esophagus. Int J Cancer 2000;89:458-64. [DOI: 10.1002/1097-0215(20000920)89:5<458::aid-ijc10>3.0.co;2-r] [Cited by in Crossref: 75] [Cited by in F6Publishing: 76] [Article Influence: 3.4] [Reference Citation Analysis]
71 Sun Y, Keshava C, Sharp DS, Weston A, McCanlies EC. DNA sequence variants of p53: cancer and aging. Am J Hum Genet 1999;65:1779-82. [PMID: 10577934 DOI: 10.1086/302650] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 0.8] [Reference Citation Analysis]
72 Giannoudis A, Graham DA, Southern SA, Herrington CS. p53 codon 72 ARG/PRO polymorphism is not related to HPV type or lesion grade in low- and high-grade squamous intra-epithelial lesions and invasive squamous carcinoma of the cervix. Int J Cancer 1999;83:66-9. [DOI: 10.1002/(sici)1097-0215(19990924)83:1<66::aid-ijc13>3.0.co;2-k] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 1.2] [Reference Citation Analysis]
73 Wang YC, Lee HS, Chen SK, Chang YY, Chen CY. Prognostic significance of p53 codon 72 polymorphism in lung carcinomas. Eur J Cancer. 1999;35:226-230. [PMID: 10448264 DOI: 10.1016/s0959-8049(98)00369-4] [Cited by in Crossref: 66] [Cited by in F6Publishing: 62] [Article Influence: 2.9] [Reference Citation Analysis]
74 Yu MW, Yang SY, Chiu YH, Chiang YC, Liaw YF, Chen CJ. A p53 genetic polymorphism as a modulator of hepatocellular carcinoma risk in relation to chronic liver disease, familial tendency, and cigarette smoking in hepatitis B carriers. Hepatology 1999;29:697-702. [PMID: 10051470 DOI: 10.1002/hep.510290330] [Cited by in Crossref: 88] [Cited by in F6Publishing: 95] [Article Influence: 3.8] [Reference Citation Analysis]
75 Storey A, Thomas M, Kalita A, Harwood C, Gardiol D, Mantovani F, Breuer J, Leigh IM, Matlashewski G, Banks L. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature. 1998;393:229-234. [PMID: 9607760 DOI: 10.1038/30400] [Cited by in Crossref: 615] [Cited by in F6Publishing: 594] [Article Influence: 25.6] [Reference Citation Analysis]
76 Tagawa M, Murata M, Kimura H. Prognostic value of mutations and a germ line polymorphism of the p53 gene in non-small cell lung carcinoma: association with clinicopathological features. Cancer Letters 1998;128:93-9. [DOI: 10.1016/s0304-3835(98)00056-1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 0.8] [Reference Citation Analysis]
77 Welsh JA, Castrén K, Vähäkangas KH. Single-strand conformation polymorphism analysis to detect p53 mutations: characterization and development of controls. Clinical Chemistry 1997;43:2251-5. [DOI: 10.1093/clinchem/43.12.2251] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
78 Weston A, Godbold JH. Polymorphisms of H-ras-1 and p53 in breast cancer and lung cancer: a meta-analysis. Environ Health Perspect 1997;105 Suppl 4:919-26. [PMID: 9255581 DOI: 10.1289/ehp.97105s4919] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 1.7] [Reference Citation Analysis]
79 Miller YE, Franklin WA. Molecular events in lung carcinogenesis. Hematol Oncol Clin North Am 1997;11:215-34. [PMID: 9137967 DOI: 10.1016/s0889-8588(05)70427-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]